Real-world efficacy and safety of efgartigimod in patients with autoimmune encephalitis: a single-center retrospective analysiss
This study was conducted to evaluate the efficacy and safety of efgartigimod (EFG), a neonatal Fc receptor (FcRn) antagonist, in the treatment of autoimmune encephalitis (AE) under real-world conditions and to provide clinical evidence for treating AE patients who respond poorly to first-line and/or second-line imm...